Cargando…

Glucose metabolism and tumour microenvironment in pancreatic cancer: A key link in cancer progression

Early and accurate diagnosis and treatment of pancreatic cancer (PC) remain challenging endeavors globally. Late diagnosis lag, high invasiveness, chemical resistance, and poor prognosis are unresolved issues of PC. The concept of metabolic reprogramming is a hallmark of cancer cells. Increasing evi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Shi, Li, Wancheng, Li, Xin, Wang, Zhengfeng, Chen, Zhou, Shi, Huaqing, He, Ru, Chen, Chen, Zhou, Wence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792100/ https://www.ncbi.nlm.nih.gov/pubmed/36578477 http://dx.doi.org/10.3389/fimmu.2022.1038650

Ejemplares similares

Pancreatic stellate cells in pancreatic cancer: as potential targets for future therapy
por: Wang, Zhengfeng, et al.
Publicado: (2023)

Association of the Microbiota and Pancreatic Cancer: Opportunities and Limitations
por: Chen, Zhou, et al.
Publicado: (2022)

Integrated transcriptomics, proteomics and metabolomics-based analysis uncover TAM2-associated glycolysis and pyruvate metabolic remodeling in pancreatic cancer
por: Li, Xin, et al.
Publicado: (2023)

Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions
por: Chen, Zhou, et al.
Publicado: (2023)

Nomograms for Predicting the Risk and Prognosis of Liver Metastases in Pancreatic Cancer: A Population-Based Analysis
por: Shi, Huaqing, et al.
Publicado: (2023)

Understanding Necroptosis in Pancreatic Diseases
por: He, Ru, et al.
Publicado: (2022)

Betulinic acid-mediating miRNA-365 inhibited the progression of pancreatic cancer
por: LI, XIN, et al.
Publicado: (2023)

A nomogram for predicting survival in patients with advanced (stage III/IV) pancreatic body tail cancer: a SEER-based study
por: Shi, Huaqing, et al.
Publicado: (2022)

STAT3 Inhibitors: A Novel Insight for Anticancer Therapy of Pancreatic Cancer
por: Li, Xin, et al.
Publicado: (2022)

Comprehensive Analysis Identifies PKP3 Overexpression in Pancreatic Cancer Related to Unfavorable Prognosis
por: Du, Yan, et al.
Publicado: (2023)

Current understanding of ferroptosis in the progression and treatment of pancreatic cancer
por: Dong, Shi, et al.
Publicado: (2021)

Integrated bioinformatics analysis of potential biomarkers for pancreatic cancer
por: Shi, Huaqing, et al.
Publicado: (2022)

Challenges and Opportunities Associated With Platelets in Pancreatic Cancer
por: Chen, Zhou, et al.
Publicado: (2022)

Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Reveals That TAM2-Driven Genes Affect Immunotherapeutic Response and Prognosis in Pancreatic Cancer
por: Du, Yan, et al.
Publicado: (2023)

Immunocyte Infiltration Analysis and Immunohistochemistry Identify EVL as a Potential Prognostic Biomarker for Pancreatic Cancer
por: Du, Yan, et al.
Publicado: (2023)

Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU)
por: Hosen, S. M. Zahid, et al.
Publicado: (2022)

Microbiota in cancer: molecular mechanisms and therapeutic interventions
por: Chen, Zhou, et al.
Publicado: (2023)

Pancreatic cancer and fibrosis: Targeting metabolic reprogramming and crosstalk of cancer-associated fibroblasts in the tumor microenvironment
por: Li, Xin, et al.
Publicado: (2023)

New challenges for microRNAs in acute pancreatitis: progress and treatment
por: Zhou, Wence, et al.
Publicado: (2022)

The Pan-Cancer Landscape of Crosstalk Between TRP Family and Tumour Microenvironment Relevant to Prognosis and Immunotherapy Response
por: Wu, Gujie, et al.
Publicado: (2022)

Epigenetic Underpinnings of Inflammation: A Key to Unlock the Tumor Microenvironment in Glioblastoma
por: Chen, Nian, et al.
Publicado: (2022)

High expression ITGA2 affects the expression of MET, PD-L1, CD4 and CD8 with the immune microenvironment in pancreatic cancer patients
por: Jin, Liquan, et al.
Publicado: (2023)

A Novel TGF-β Risk Score Predicts the Clinical Outcomes and Tumour Microenvironment Phenotypes in Bladder Cancer
por: Liu, Zhi, et al.
Publicado: (2021)

Neoadjuvant therapy alters the immune microenvironment in pancreatic cancer
por: Zhang, Huiru, et al.
Publicado: (2022)

Interplay between the Human Microbiome and Biliary Tract Cancer: Implications for Pathogenesis and Therapy
por: Ye, Cheng, et al.
Publicado: (2023)

Unveiling the interplay between mutational signatures and tumor microenvironment: a pan-cancer analysis
por: Luo, Li-Zhi, et al.
Publicado: (2023)

A DNA-Methylation-Driven Genes Based Prognostic Signature Reveals Immune Microenvironment in Pancreatic Cancer
por: Xiao, Mingjia, et al.
Publicado: (2022)

Tumor Microenvironment Evaluation for Gastrointestinal Cancer in the Era of Immunotherapy and Machine Learning
por: Ye, Zilan, et al.
Publicado: (2022)

Identifying a baicalein-related prognostic signature contributes to prognosis prediction and tumor microenvironment of pancreatic cancer
por: Zhang, Citing, et al.
Publicado: (2023)

An integrated overview of the immunosuppression features in the tumor microenvironment of pancreatic cancer
por: Guo, Jinglong, et al.
Publicado: (2023)

Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer
por: Guo, Yongdong, et al.
Publicado: (2021)

Interplay of four types of RNA modification writers revealed distinct tumor microenvironment and biological characteristics in pancreatic cancer
por: Gao, Wenzhe, et al.
Publicado: (2022)

The circadian rhythm key gene ARNTL2: a novel prognostic biomarker for immunosuppressive tumor microenvironment identification and immunotherapy outcome prediction in human cancers
por: Wu, Gujie, et al.
Publicado: (2023)

Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2021)

FUCA2 Is a Prognostic Biomarker and Correlated With an Immunosuppressive Microenvironment in Pan-Cancer
por: Zhong, Anyuan, et al.
Publicado: (2021)

Innate immunity in pancreatic cancer: Lineage tracing and function
por: Ye, Longyun, et al.
Publicado: (2023)

Biological Roles and Pathogenic Mechanisms of LncRNA MIR4435-2HG in Cancer: A Comprehensive Review
por: Chen, Zhou, et al.
Publicado: (2023)

Orthotopic and Heterotopic Murine Models of Pancreatic Cancer Exhibit Different Immunological Microenvironments and Different Responses to Immunotherapy
por: Wang, Jin, et al.
Publicado: (2022)

Regulation of epigenetic modifications in the head and neck tumour microenvironment
por: Liu, Huimin, et al.
Publicado: (2022)

Neutrophils in pancreatic cancer: Potential therapeutic targets
por: Jiang, Wenkai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6e8arhg3bl2cnmjec82imu9vl0